Note: Ingredients listed on restricted chemical lists
EC/CAS
202-805-4/99-97-8
Name of the chemical
N,N-dimethyl-p-toluidine
Concentration
<1
General Information
Revision date
2018-12-04
Product name
DELO -ML 5298
1.2.1 Relevant identified uses
Process categories [PROC
supplier name
DELO Industrie Klebstoffe GmbH & Co. KGaA
Emergency telephone
+49 (0) 551 19240, +44 (0) 1235 239 670
Icons in SDS
Company Information
company name
DELO Industrie Klebstoffe GmbH & Co. KGaA
e-mail address of the competent person responsible for the Safety Data Sheet
msds@DELO.de
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H319, H335
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mixture
Signal word
Warning
Hazard statements
Causes serious eye irritation. Causes skin irritation. May cause respiratory irritation.
Prevention
Wear protective gloves 1 - 4 hours (breakthrough time) Recommended Viton® fluor rubber / Short term exposure < 15 min Nitrile gloves.. Wear eye or face protection. Avoid breathing vapour.
Response
IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER or physician if you feel unwell.
Storage
Store locked up.
Disposal
Dispose of contents and container in accordance with all local, regional, national and international regulations.
Hazardous Ingredients
α,α-dimethylbenzyl hydroperoxide
Supplemental label elements
Not applicable.
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
Not applicable.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Skin Irrit. 2, H315 Eye Irrit. 2, H319 STOT SE 3, H335 The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
